M. A. Ak Et Al. , "The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.," Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2, pp.299-308, 2022
Ak, M. A. Et Al. 2022. The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2 , 299-308.
Ak, M. A., Sahip, B., Geduk, A., Ucar, M. A., Kale, H., Hacibekiroglu, T., ... Polat, M. G.(2022). The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2, 299-308.
Ak, Muzeyyen Et Al. "The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.," Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2, 299-308, 2022
Ak, Muzeyyen A. Et Al. "The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2, pp.299-308, 2022
Ak, M. A. Et Al. (2022) . "The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.38, no.2, pp.299-308.
@article{article, author={Muzeyyen Aslaner Ak Et Al. }, title={The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.}, journal={Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion}, year=2022, pages={299-308} }